Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene

Cancer Genetics and Cytogenetics

Volumn 135, Issue 1, 2002, Pages 48-56

  Moritake, Hiroshi ^a   Sugimoto, Tohru ^b   Asada, Yujiro ^a   Yoshida, Mitsuaki A ^c   Maehara, Yoshihiko ^d   Epstein, Alan L ^e   Kuroda, Hiroshi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c National Hospital Organization   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CANCER GENETICS; CASE REPORT; CELL LINE; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; CLEAR CELL SARCOMA; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MELANOMA CELL; MELANOSOME; METASTASIS; PRIORITY JOURNAL;

ACHILLES TENDON; ADOLESCENT; ANTIGENS, NEOPLASM; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOSOMES; MUTAGENESIS, INSERTIONAL; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, CLEAR CELL; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

INSERTION SEQUENCES;

EID: 0036267896     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00641-0     Document Type: Article

References (39)

1. Clear-cell sarcoma of tendons and aponeuroses; an analysis of 21 cases
2. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
3. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
4. Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis
5. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
6. Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts
7. t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma
8. Clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) diagnosed initially as malignant melanoma
9. Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma
10. Establishment and characterization of a new human clear-cell sarcoma cell-line, HS-MM
11. Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line
12. Newly established MST-1 tumour cell line and tumour-infiltrating lymphocyte culture from a patient with soft tissue melanoma (clear cell sarcoma) and their potential applications to patient immunotherapy
13. Establishment of a new continuous clear cell sarcoma cell line
14. A model of human cancer metastasis; Extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice
15. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
16. Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes
17. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies; use in the characterization of the human melanoma antigen MART-1
18. Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes
19. Rearrangements of chromosome 3 in non-familial renal cell carcinomas from Japanese patients
20. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts)
21. Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy
22. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line
23. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells
24. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vitro
25. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
26. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
27. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma; Exploring the histogenetic relationship between these two clinicopathological entities
28. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF-1 oncogene
29. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator
30. Cytogenetic study of chronic myeloid leukemia
31. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia; A comparison of banding and fluorescence in situ hybridization
32. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization
33. Abnormal chromosome 8 copy number in stage I to stage IV breast cancer studied by fluorescence in situ hybridization
34. c-MYC amplification in a case of progression from MDS to AML (M2)
35. Determination of c-myc amplification and overexpression in breast cancer patients; Evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis
36. Increased c-myc oncogene expression in Ewing's sarcoma; correlation with Ki67 proliferation index
37. Identification of c-MYC as a target of the APC pathway